Aarey Drugs & Pharmaceuticals Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Aarey Drugs & Pharmaceuticals' board has approved its Q1 FY26 unaudited financial results. The company saw robust YoY growth, with revenue from operations soaring to Rs 9.62 Cr, a significant leap from Rs 1.11 Cr last year. Profit for the quarter also climbed sharply to Rs 0.57 Cr, up from Rs 0.12 Cr. Aarey Drugs operates solely in the drug manufacturing and trading segment.